MRTX Headlines | Mirati Therapeutics, Inc. Stock - Yahoo! Finance

Wed, Oct 2, 2013, 2:44AM EDT - U.S. Markets open in 6 hrs 46 mins

Dow

0.41% Nasdaq

1.23%

More On MRTX

Quotes

Charts

News & Info

Headlines
Press Releases
Company Events
Message Boards
Market Pulse

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Ownership

Financials

Income Statement
Balance Sheet
Cash Flow

Mirati Therapeutics, Inc. (MRTX)

-NasdaqCM

17.66 2.51(16.57%) Oct 1, 4:00PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Tuesday, October 1, 2013

MIRATI THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal ActivitiesEDGAR Online (Tue, Oct 1)

Friday, September 13, 2013

Wall Street Transcript Interview with Dr. Charles M. Baum, the President and CEO of Mirati Therapeutics, Inc. (MRTX)Wall Street Transcript (Fri, Sep 13)

Thursday, September 5, 2013

MIRATI THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhEDGAR Online (Thu, Sep 5)

Wednesday, September 4, 2013

Mirati Therapeutics Appoints Isan Chen as Chief Medical and Development Officer and Adds Craig Johnson to Board of DirectorsMarketwired (Wed, Sep 4)
Mirati Therapeutics Appoints Isan Chen as Chief Medical and Development Officer and Adds Craig Johnson to Board of DirectorsMarketwired (Wed, Sep 4)

Tuesday, August 13, 2013

MIRATI THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Aug 13)

Monday, August 12, 2013

Mirati Therapeutics Reports Second Quarter 2013 Financial ResultsMarketwired (Mon, Aug 12)
Mirati Therapeutics Reports Second Quarter 2013 Financial ResultsMarketwired (Mon, Aug 12)
MIRATI THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online (Mon, Aug 12)

Monday, August 5, 2013

Mirati: Reborn After Reincorporation In The U.S. And Nasdaq Listingat Seeking Alpha (Mon, Aug 5)

Tuesday, July 23, 2013

Mirati Therapeutics: Revamped And Ready To Go With A Targeted Oncology Pipelineat Seeking Alpha (Tue, Jul 23)

Monday, July 22, 2013

MIRATI THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or SEDGAR Online (Mon, Jul 22)

Friday, July 19, 2013

Mirati Therapeutics to Voluntarily Delist from TSXMarketwired (Fri, Jul 19)
Mirati Therapeutics to Voluntarily Delist from TSXMarketwired (Fri, Jul 19)

Thursday, July 18, 2013

LifeSci Advisors Initiates Coverage of Mirati TherapeuticsMarketwired (Thu, Jul 18)

Tuesday, July 16, 2013

Mirati Therapeutics: A U.S. Company With Targeted Therapy in FocusZacks Small Cap Research (Tue, Jul 16)

Monday, July 15, 2013

Mirati Therapeutics to Commence Trading on the NASDAQMarketwired (Mon, Jul 15)
Mirati Therapeutics to Commence Trading on the NASDAQMarketwired (Mon, Jul 15)

Older Headlines

Add MRTX News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.